BROOKS LABORATORIES
|
The Current P/E Ratio of BROOKS LABORATORIES is 42.73.
| Share Price | ₹66.3 | Sep 11,2026 |
| Market Cap | ₹195.4 Cr | |
| Earnings-TTM | ₹4.6 Cr | TTM-Consolidated Results |
| Price/Earnings | 42.73x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of BROOKS LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹195.4 Cr] as on Sep 11,2026
(/) Earnings [ ₹4.6 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 42.73x ]
Thus, for BROOKS LABORATORIES , the investors are currently willing to pay 42.73 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BROOKS LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of BROOKS LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of BROOKS LABORATORIES
PE Ratio Performance Analysis for BROOKS LABORATORIES
- BROOKS LABORATORIES 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 0.90x.
- BROOKS LABORATORIES 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BROOKS LABORATORIES 's p/e ratio peaked in Mar2026 at 4.49x.
- BROOKS LABORATORIES 's p/e ratio hit its five-year low in Mar2025 of 0x.
How does BROOKS LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| BROOKS LABORATORIES | 4.57 | 42.73 | 195.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 12,172.70 | 36.31 | 441,958.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 84.64 | 247,576.0 |
| TORRENT PHARMACEUTICALS LTD | 2,156.00 | 87.77 | 189,233.0 |
| CIPLA LTD | 3,364.84 | 32.77 | 110,273.0 |
| DR REDDYS LABORATORIES LTD | 3,169.30 | 30.58 | 96,906.4 |
| MANKIND PHARMA LTD | 2,055.11 | 45.76 | 94,050.4 |
| LUPIN LTD | 5,551.01 | 17.27 | 95,842.9 |
| ZYDUS LIFESCIENCES LTD | 4,492.20 | 24.86 | 111,671.0 |
| AUROBINDO PHARMA LTD | 3,712.74 | 25.97 | 96,401.7 |
| LAURUS LABS LTD | 1,090.76 | 97.60 | 106,460.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs BROOKS LABORATORIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 17.27x |
| Max industry PE | 97.60x |
| Median industry PE | 36.31x |
| Average industry PE | 47.84x |
You may also like the below Video Courses